HomeTop StoriesAkhanda Collections: dethrones Vakeel Saab and Love Story, becomes Highest opening grosser...

Akhanda Collections: dethrones Vakeel Saab and Love Story, becomes Highest opening grosser for any Telugu film in 2021

Akhanda Collections: dethrones Vakeel Saab and Love Story, becomes Highest opening grosser for any Telugu film in 2021
Akhanda Collections: dethrones Vakeel Saab and Love Story, becomes Highest opening grosser for any Telugu film in 2021

Akhanda collections: After delivering two blockbuster movies –  Legend  and  Simha, director Boyapati Srinu and actor Balakrishna teamed up for their third film – a mass masala entertainer  Akhanda, which arrived at the theaters today on 2nd December. The movie is winning the hearts of the movie lovers.

Now according to the traders report, Akhanda has crushed the collections record of the Sekhar Kammula’ magnum opus Love Story starring Akkineni Naga Chaitanya and Sai Pallavi, and also the record of Power Star Pawan Kalyan starrer court room drama Vakeel Saab at the USA box office and, finally has become the Highest opening grosser for any Telugu film in 2021 in overseas.

Advertisement

Akhanda  collected 325 K dollars through premiere shows in North America, and in this manner, the movie dethroned previous best- Love Story which grossed around $313K in the territory and also crushed the record of Pawan Kalyan’s Vakeel Saab  which collected $300k through premiere shows.

In Akhanda, Balakrishna is playing the dual role and his role as Aghora is highlighted.  The  movie marked Balayya’ first collaboration with  Kanche lady Pragya Jaiswal. The movie is bankrolled by Miryala Ravinder Reddy and has the music by Thaman. Srikanth is playing the role of villain and Boyapati’ film also has JagapathiBabu, Srikanth, Avinash, Poorna, Subbaraju and others in the crucial roles.

Also Read:

Akhanda Movie Review

Akhanda USA Premier collections update

Akhanda Twitter review

Kamma community builds hype for Balakrishna Akhanda

Advertisement
Advertisement
Advertisement

Top Stories

View All
Advertisement

Gossips

View All
Advertisement